MBNL1 and myotonic dystrophy type 1: In the current study, we found that COX-inhibitions increased MBNL1 ~1.5-folds (Fig. 2 and Supplementary Fig. S1c), which is likely to sufficient to exert some beneficial effects in DM1 cells.